160 related articles for article (PubMed ID: 38144272)
1. Pharmacokinetics and bioequivalence of
Kim SK; Venkatesan J; Rathi P; Antony B
Heliyon; 2023 Dec; 9(12):e22843. PubMed ID: 38144272
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic Study of Withanosides and Withanolides from
Modi SJ; Tiwari A; Ghule C; Pawar S; Saste G; Jagtap S; Singh R; Deshmukh A; Girme A; Hingorani L
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268576
[No Abstract] [Full Text] [Related]
4. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
5. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
6. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract.
Patil D; Gautam M; Mishra S; Karupothula S; Gairola S; Jadhav S; Pawar S; Patwardhan B
J Pharm Biomed Anal; 2013 Jun; 80():203-12. PubMed ID: 23584079
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAĻ receptors.
Candelario M; Cuellar E; Reyes-Ruiz JM; Darabedian N; Feimeng Z; Miledi R; Russo-Neustadt A; Limon A
J Ethnopharmacol; 2015 Aug; 171():264-72. PubMed ID: 26068424
[TBL] [Abstract][Full Text] [Related]
8. Investigating 11 Withanosides and Withanolides by UHPLC-PDA and Mass Fragmentation Studies from Ashwagandha (
Girme A; Saste G; Pawar S; Balasubramaniam AK; Musande K; Darji B; Satti NK; Verma MK; Anand R; Singh R; Vishwakarma RA; Hingorani L
ACS Omega; 2020 Nov; 5(43):27933-27943. PubMed ID: 33163776
[No Abstract] [Full Text] [Related]
9. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
[No Abstract] [Full Text] [Related]
10. Withania somnifera root extract inhibits MGO-induced skin fibroblast cells dysfunction via ECM-integrin interaction.
Liu X; Chen C; Lin Y; Liu Y; Cai S; Li D; Li L; Xiao P; Yi F
J Ethnopharmacol; 2024 Apr; 323():117699. PubMed ID: 38185262
[TBL] [Abstract][Full Text] [Related]
11. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin.
Dubey S; Kallubai M; Sarkar A; Subramanyam R
PLoS One; 2018; 13(11):e0200053. PubMed ID: 30403672
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the bioavailability of major withanolides of Withania somnifera using an in vitro absorption model system.
Devkar ST; Kandhare AD; Sloley BD; Jagtap SD; Lin J; Tam YK; Katyare SS; Bodhankar SL; Hegde MV
J Adv Pharm Technol Res; 2015; 6(4):159-64. PubMed ID: 26605156
[TBL] [Abstract][Full Text] [Related]
14. RNAi of Sterol Methyl Transferase1 Reveals its Direct Role in Diverting Intermediates Towards Withanolide/Phytosterol Biosynthesis in Withania somnifera.
Pal S; Rastogi S; Nagegowda DA; Gupta MM; Shasany AK; Chanotiya CS
Plant Cell Physiol; 2019 Mar; 60(3):672-686. PubMed ID: 30541044
[TBL] [Abstract][Full Text] [Related]
15. Withanolides from
Khanal P; Chikhale R; Dey YN; Pasha I; Chand S; Gurav N; Ayyanar M; Patil BM; Gurav S
J Biomol Struct Dyn; 2022 Aug; 40(12):5295-5308. PubMed ID: 33459174
[TBL] [Abstract][Full Text] [Related]
16. A blend of Withania somnifera (L.) Dunal root and Abelmoschus esculentus (L.) Moench fruit extracts relieves constipation and improves bowel function: A proof-of-concept clinical investigation.
Punukollu RS; Chadalawada AK; Siddabattuni K; Gogineni NT
J Ethnopharmacol; 2024 Jan; 318(Pt B):116997. PubMed ID: 37543151
[TBL] [Abstract][Full Text] [Related]
17. Integrated System Pharmacology and
Hannan MA; Dash R; Haque MN; Choi SM; Moon IS
CNS Neurol Disord Drug Targets; 2020; 19(7):541-556. PubMed ID: 32748763
[TBL] [Abstract][Full Text] [Related]
18. Withanolide biosynthesis recruits both mevalonate and DOXP pathways of isoprenogenesis in Ashwagandha Withania somnifera L. (Dunal).
Chaurasiya ND; Sangwan NS; Sabir F; Misra L; Sangwan RS
Plant Cell Rep; 2012 Oct; 31(10):1889-97. PubMed ID: 22733207
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of withanolide biosynthesis in relation to temporal expression pattern of metabolic genes in Withania somnifera (L.) Dunal: a comparative study in two morpho-chemovariants.
Dhar N; Rana S; Bhat WW; Razdan S; Pandith SA; Khan S; Dutt P; Dhar RS; Vaishnavi S; Vishwakarma R; Lattoo SK
Mol Biol Rep; 2013 Dec; 40(12):7007-16. PubMed ID: 24190485
[TBL] [Abstract][Full Text] [Related]
20.
Holvoet H; Long DM; Law A; McClure C; Choi J; Yang L; Marney L; Poeck B; Strauss R; Stevens JF; Maier CS; Soumyanath A; Kretzschmar D
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
